Your session is about to expire
ENDURE Trial Summary
This trial is testing a new drug to see if it is safe and effective in preventing COVID-19.
- COVID-19
ENDURE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ENDURE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had an allergic reaction to any ingredient in the medication.You are currently receiving treatment for cancer.You have received plasma treatment for COVID-19 in the past 90 days.You have a history of a serious bleeding disorder or have experienced significant bleeding or bruising after receiving injections or having blood drawn in the past.You have any other health condition or problem that could make it risky for you to be part of the study, make it hard for you to participate, or make it difficult to understand the study results.You have had a bad allergic reaction or severe side effects after receiving a specific type of medication called a monoclonal antibody (mAb).You have not received any experimental or approved medication for the prevention or treatment of COVID-19 in the recent past or right after enrolling in the study.You have medical conditions or treatments that weaken your immune system or may not provide a strong response to the COVID-19 vaccine.
- Group 1: Arm B
- Group 2: Arm A
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can people with the qualifying condition join this trial at present?
"The latest information available on clinicaltrials.gov indicates that this study is not actively recruiting patients at this time. The trial was first posted on June 9th, 2022 and last updated November 7th, 2022. There are 1146 other trials which are currently looking for participants."
Does this experiment exclude senior citizens?
"The age bracket for participants in this clinical trial are those that are 12 years old or above, and have not yet reached their 100th birthday."
Could you give me the screening criteria for this research project?
"The eligibility requirements for this study include a positive diagnosis of covid-19 and an age between 12 to 99 years old. So far, 251 have been accepted into the trial."
How does this treatment's safety profile compare to other available options?
"The safety of this proposed treatment falls in the middle of our 1 to 3 scale at a 2. This is due to the fact that, while there is Phase 2 clinical trial data supporting its safety, there are no trials which have evaluated efficacy."
In how many different healthcare facilities is this research project being conducted today?
"This trial is currently running at 17 sites. The locations are listed on the website and include Lake City, Miami Lakes and Modesto along with 14 other locations. If you enroll, it would be helpful to select the site that is closest to your location in order to minimize travel requirements."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger